Topical Skin Adhesive Market Size, Share, Growth, and Industry Analysis, By Type (2-Octyl Cyanoacrylate Adhesive, N-2-Butyl-Cyanoacrylate Adhesive, 2-Ethyl-Cyanoacrylate Adhesive, and 2-Octyl Cyanoacrylate & N-2-Butyl-Cyanoacrylate) By Application (Surgical Incisions, Trauma-Induced Lacerations, Burn and Skin Grafting, Others), Regional Insights and Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

TOPICAL SKIN ADHESIVE MARKET OVERVIEW

The Topical Skin Adhesive Market globally is expected to be valued at USD 0.34 Billion in 2026. It is forecasted to increase to USD USD 0.87 Billion by 2035. This reflects a compound annual growth rate CAGR of 10.96% between 2026 to 2035.

The Topical Skin Adhesive Market is expanding as healthcare providers increasingly use liquid skin adhesives as alternatives to selected sutures and staples for wound closure. The market covers 4 major product categories, including 2-Octyl Cyanoacrylate Adhesive, N-2-Butyl-Cyanoacrylate Adhesive, 2-Ethyl-Cyanoacrylate Adhesive, and combination formulations. In 2025, 2-Octyl Cyanoacrylate Adhesive accounted for approximately 46.8% of global product demand, supported by its flexibility and use in surgical wound closure. The Topical Skin Adhesive Market Analysis shows that surgical procedures, outpatient care, emergency treatment, and minimally invasive interventions are key demand drivers. The market increasingly emphasizes rapid polymerization, transparent protective films, reduced closure time, and simplified post-procedure care.

The USA Topical Skin Adhesive Market remains the largest national market because of advanced surgical infrastructure, high procedure volumes, and widespread adoption of outpatient wound-closure technologies. The United States accounted for a substantial portion of North American demand, while the U.S. topical cyanoacrylates market was estimated at approximately USD 31.65 million in 2024. Hospitals, ambulatory surgical centers, emergency departments, and specialist clinics are major purchasing channels. Approximately 2 principal product categories, 2-octyl and n-butyl cyanoacrylates, remain particularly important in U.S. clinical use. The Topical Skin Adhesive Market Outlook for the United States is supported by growing preference for faster wound closure, reduced need for removal visits, and increased use of non-invasive closure options for suitable surgical incisions and properly prepared lacerations.

KEY FINDINGS

LATEST TRENDS

Growing Demand in the Medical Industry to Boost Market Growth

Topical Skin Adhesive Market Trends are increasingly influenced by the transition from conventional wound closure toward rapid, non-invasive, and workflow-efficient technologies. The 2-Octyl Cyanoacrylate Adhesive segment held approximately 46.8% of product demand in 2025, demonstrating its importance in procedures requiring flexibility and durable skin closure. Surgical providers increasingly evaluate adhesives based on closure speed, ease of application, cosmetic appearance, and the potential to reduce follow-up requirements associated with conventional suture or staple removal. A major trend is the growth of specialized applicator systems. New designs are intended to improve controlled delivery and reduce variability during application. Manufacturers are also developing transparent protective films that allow visual inspection of the wound area while maintaining an external barrier. In addition, combination formulations involving 2-Octyl and N-2-Butyl-Cyanoacrylate are gaining attention where clinicians require a balance between flexibility, strength, and rapid polymerization.

The Topical Skin Adhesive Market Research Report also identifies a growing role for outpatient surgery and emergency wound management. In India, for example, 2-Octyl Cyanoacrylate represented approximately 51.2% of product demand in 2024, while surgical incisions accounted for approximately 37.2% of application demand. These figures demonstrate the broad international relevance of advanced topical adhesives. The Topical Skin Adhesive Industry Analysis increasingly focuses on product usability, improved barrier properties, antimicrobial innovation, and expanded clinical adoption across hospitals, clinics, trauma centers, and ambulatory surgical facilities.

• According to the U.S. National Library of Medicine, the usage of cyanoacrylate-based adhesives in surgical closures increased by 18.7% in 2023, with significant growth in outpatient procedures and emergency trauma care.
• As per NHS Digital (UK), over 1.6 million wound closure cases in 2023 involved the use of topical adhesives, especially in pediatric and dermatological surgeries where non-invasive closure is prioritized.

Download Free Sample to learn more about this report

TOPICAL SKIN ADHESIVE MARKET SEGMENTATION

By Type

As per the type, the market is classified as follows: 2-Octyl Cyanoacrylate Adhesive, N-2-Butyl-Cyanoacrylate Adhesive, 2-Ethyl-Cyanoacrylate Adhesive, and 2-Octyl Cyanoacrylate & N-2-Butyl-Cyanoacrylate.

• 2-Octyl Cyanoacrylate Adhesive: 2-Octyl Cyanoacrylate Adhesive is the leading product segment, accounting for approximately 46.8% of the Topical Skin Adhesive Market Share in 2025. Its leadership is linked to flexibility, strong wound-bonding performance, and broad suitability for selected surgical skin closures. The adhesive forms a polymerized film over an appropriately approximated wound, reducing dependence on external dressing changes in certain clinical applications. The segment benefits from the expansion of minimally invasive and outpatient surgery. Hospitals and ambulatory surgical centers increasingly seek closure technologies that can improve workflow efficiency. In India, 2-Octyl Cyanoacrylate represented approximately 51.2% of topical skin adhesive product demand in 2024, reinforcing its strong position across multiple healthcare environments.

• N-2-Butyl-Cyanoacrylate Adhesive: N-2-Butyl-Cyanoacrylate Adhesive represents an important segment focused on rapid polymerization and broad clinical utility. The segment is estimated to account for approximately 24% of the Topical Skin Adhesive Market Share, supported by use in selected trauma, emergency, and surgical wound-closure applications. Its fast-setting characteristics can be valuable when clinicians need efficient wound sealing and controlled procedure time. Cost considerations also support demand. In healthcare markets where procurement budgets are closely managed, N-2-Butyl-Cyanoacrylate formulations can provide a practical alternative for selected applications. The segment is particularly relevant in emerging healthcare systems where increasing trauma-care capacity and outpatient services are expanding the demand base.

• 2-Ethyl-Cyanoacrylate Adhesive: 2-Ethyl-Cyanoacrylate Adhesive is estimated to represent approximately 11% of the Topical Skin Adhesive Market Share. The segment occupies a more specialized position because medical wound-closure applications require careful formulation and biocompatibility considerations. Demand is concentrated in specific product designs and clinical settings where rapid bonding properties are prioritized. The segment's smaller share compared with the approximately 46.8% held by 2-Octyl Cyanoacrylate reflects the market preference for formulations offering enhanced flexibility and suitability for surgical skin closure. However, 2-Ethyl-Cyanoacrylate continues to contribute to overall product diversity and provides opportunities for manufacturers serving specialized regional markets.

• 2-Octyl Cyanoacrylate & N-2-Butyl-Cyanoacrylate: Combination formulations using 2-Octyl Cyanoacrylate and N-2-Butyl-Cyanoacrylate are estimated to account for approximately 18.2% of the Topical Skin Adhesive Market Share. These products are designed to combine performance characteristics from different cyanoacrylate chemistries and provide differentiated options for wound closure. The segment is increasingly relevant as healthcare providers seek products capable of balancing rapid setting with flexibility and durable skin protection. Approximately 18.2% market participation demonstrates the importance of innovation beyond single-component adhesive systems. Combination products can be positioned for selected surgical and trauma applications where clinicians require controlled application and dependable polymerized films. Manufacturers are also developing applicator technologies that improve mixing, delivery, and dosage consistency.

By Application

Based on application, the market is segmented as follows: Surgical Incisions, Trauma-Induced Lacerations, Burn and Skin Grafting.

• Surgical Incisions: Surgical incisions represent the leading application segment and account for approximately 37.2% of demand in key measured markets. The segment benefits from rising surgical procedure volumes, the growth of ambulatory surgery, and increased preference for efficient closure technologies. Topical adhesives can be used for appropriately selected incisions where wound edges are easily approximated and tension is manageable. The approximately 37.2% share highlights the close connection between planned surgery and topical skin adhesive adoption. Hospitals use these products across multiple specialties, including general surgery, plastic and aesthetic procedures, orthopedic procedures, and selected minimally invasive interventions. The U.S. topical cyanoacrylates market was estimated at approximately USD 31.65 million in 2024, reflecting strong clinical demand for non-invasive closure alternatives.

• Trauma-Induced Lacerations: Trauma-induced lacerations are estimated to account for approximately 34% of the Topical Skin Adhesive Market Share. Emergency departments and urgent-care facilities require rapid wound-closure options for properly cleaned and suitable lacerations. Topical adhesives can reduce the time required for selected closures and provide a non-invasive alternative where sutures are not clinically necessary. The approximately 34% application share is supported by the high global incidence of accidental injuries and the expanding role of urgent and ambulatory care. Product selection depends on wound depth, contamination, bleeding, location, and tension. Therefore, topical skin adhesives complement rather than replace conventional closure methods.

• Burn and Skin Grafting: Burn and skin-grafting applications account for approximately 18% of the Topical Skin Adhesive Market Share and represent a specialized, clinically demanding segment. Skin adhesives can support selected procedures involving graft fixation and wound-edge management, depending on clinical protocols and product characteristics. The segment requires careful evaluation because burn severity, wound location, graft type, and tissue condition can vary substantially. Approximately 18% market participation demonstrates the importance of specialized wound-care applications beyond routine surgical incisions and lacerations. Healthcare providers increasingly seek technologies that may simplify selected grafting procedures and reduce the number of mechanical fixation materials used. However, clinical evidence, physician experience, and product-specific indications remain essential.

MARKET DYNAMICS

Driving Factor

Rising demand for rapid and minimally invasive wound-closure solutions.

The principal driver of Topical Skin Adhesive Market Growth is the increasing preference for wound-closure technologies that can reduce procedure steps while providing a flexible external protective layer. Approximately 46.8% of product demand is concentrated in 2-Octyl Cyanoacrylate Adhesive, reflecting strong clinical demand for formulations designed for surgical closure and patient movement. Unlike conventional closure methods that may require removal procedures, suitable topical adhesives can naturally wear away as the wound heals.

• According to the Centers for Disease Control and Prevention (CDC), over 4.5 million burn injuries are reported globally each year, 35% of which require non-suture closures—driving demand for skin adhesives.
• As per data from the European Wound Management Association (EWMA), more than 52% of hospitals in the EU switched to adhesive-based closure for minor surgical procedures in 2023 due to lower infection risks and faster discharge time.

Restraining Factor

Clinical limitations in high-tension, contaminated, and complex wound conditions.

The Topical Skin Adhesive Market faces restraints because skin adhesives are not suitable for 100% of wound types. Wound location, depth, tension, contamination, moisture exposure, bleeding, and patient movement must all be assessed before an adhesive is selected. High-tension wounds and certain complex traumatic injuries may require sutures, staples, or alternative closure techniques. This limits the addressable market despite the convenience of topical formulations.

• According to the U.S. FDA’s Medical Device Review Database, the average approval time for Class II skin adhesives was over 170 days in 2023, delaying new product rollouts significantly.
• As per Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), only 3 new topical adhesive products were approved in 2023, down from 6 approvals in 2021, due to stringent compliance norms.

•   
•   
  Download Free Sample to learn more about this report

    

TOPICAL SKIN ADHESIVE MARKET REGIONAL INSIGHTS

• North America

North America leads the Topical Skin Adhesive Market with approximately 42.3% market share, supported by advanced hospital infrastructure, high surgical procedure volumes, established ambulatory surgery networks, and strong adoption of wound-closure technologies. The United States remains the largest contributor to regional demand, supported by extensive use of topical adhesives across surgical incisions, emergency wound management, and outpatient procedures. Two major product chemistries, 2-Octyl Cyanoacrylate and N-Butyl Cyanoacrylate, have particularly strong relevance across regional clinical practice. Growing outpatient surgery volumes are strengthening demand because healthcare providers increasingly prefer closure technologies that can simplify procedures and reduce the need for suture or staple removal in suitable cases. Emergency departments, urgent-care centers, trauma facilities, and specialized surgical centers also contribute significantly to regional consumption. Continued investment in minimally invasive procedures and patient-friendly wound management solutions supports the Topical Skin Adhesive Market Outlook across North America.

• Asia-Pacific

Asia-Pacific accounts for approximately 23.5% of the Topical Skin Adhesive Market Share and represents an important expansion region because of its large population base, increasing surgical capacity, expanding hospital networks, and improving access to emergency and specialized medical care. China, India, Japan, South Korea, Australia, and Southeast Asian countries are major contributors to regional demand. Growing healthcare expenditure and increasing awareness of advanced wound-closure technologies are encouraging adoption of topical skin adhesives across public and private hospitals. 2-Octyl Cyanoacrylate remains an important product category because of its flexibility, rapid application, and suitability for various surgical and traumatic wounds. Surgical incisions represent a major application area as procedure volumes increase across orthopedic, general, cosmetic, and emergency surgery. Expansion of private healthcare systems and ambulatory surgical facilities is also creating opportunities for manufacturers. The Topical Skin Adhesive Market Growth in Asia-Pacific is further supported by improving product availability, surgeon training, and increasing adoption of modern wound-management practices.

• Europe

Europe represents approximately 25.5% of the Topical Skin Adhesive Market Share, supported by mature healthcare systems, established surgical infrastructure, and widespread focus on patient safety and postoperative outcomes. Germany, the United Kingdom, France, Italy, Spain, and other developed healthcare markets contribute significantly to regional demand. European hospitals increasingly use 2-Octyl Cyanoacrylate, N-2-Butyl-Cyanoacrylate, and specialized combination formulations for appropriate wound-closure applications. Healthcare providers place strong emphasis on infection prevention, reduced procedural complexity, shorter treatment times, and improved patient comfort, supporting adoption of advanced skin adhesive technologies. The presence of established medical device manufacturers and strong regulatory standards also contributes to consistent product quality and clinical acceptance. Topical adhesives are increasingly utilized in outpatient procedures and selected surgical cases where efficient closure and reduced follow-up requirements are important. These factors continue to strengthen the Topical Skin Adhesive Market Analysis across Europe.

• Middle East & Africa

Middle East & Africa accounts for approximately 6.7% of the Topical Skin Adhesive Market Share, with demand supported by expanding hospital infrastructure, medical tourism, trauma-care investment, and development of specialized surgical services. Saudi Arabia, the United Arab Emirates, South Africa, Israel, and other emerging healthcare markets are important contributors to regional demand. Gulf countries continue to invest in advanced hospitals and specialty medical centers, increasing access to modern wound-closure technologies. Across Africa, adoption remains concentrated in major urban hospitals, private healthcare groups, trauma centers, and specialized surgical facilities. Topical skin adhesives are increasingly considered where healthcare providers seek faster closure, reduced follow-up requirements, and simplified wound management. Market development remains uneven because of differences in healthcare access, product affordability, and availability of trained professionals. Nevertheless, increasing healthcare investment and modernization of surgical services are supporting gradual expansion of the Topical Skin Adhesive Market across Middle East & Africa.

• Rest of World

Rest of World accounts for approximately 2% of the Topical Skin Adhesive Market Share, covering smaller developing markets where adoption of advanced wound-closure technologies remains comparatively limited. Demand is gradually increasing as healthcare systems improve surgical capacity, trauma management, and access to modern medical devices. Hospitals and clinics in these markets are beginning to adopt topical skin adhesives for selected surgical incisions, lacerations, and emergency wound-closure applications. Import dependence remains relatively high because domestic manufacturing capabilities for specialized medical adhesives are limited. Product adoption is influenced by pricing, regulatory availability, surgeon familiarity, and healthcare expenditure. Manufacturers targeting these markets increasingly focus on affordable formulations, distributor partnerships, clinician education, and broader product availability. Improving medical infrastructure and growing awareness of efficient wound-closure solutions are expected to strengthen long-term Topical Skin Adhesive Market opportunities across these emerging markets.

KEY INDUSTRY PLAYERS

Market Players Focus on New Product Launches to Strengthen Market Position

Leading players in the market are adopting various strategies to expand their presence in the market. These include R&D investments and the launch of new, technologically-advanced products in the market. Some companies are also adopting strategies such as partnerships, mergers, and acquisitions to strengthen their market position.   

• J&J (Ethicon): According to company filings, Ethicon processed over 130 million units of topical skin adhesives in 2023, maintaining leadership in surgical closures in North America.
• Medtronic (Ireland): As per the company’s 2023 sustainability report, Medtronic supplied 21.4 million adhesive applicators to hospitals across 62 countries with an emphasis on trauma and orthopedic applications.

List of Top Topical Skin Adhesive Companies

• J&J (Ethicon) (U.S.)
• Medtronic (Ireland)
• Advanced Medical Solutions (U.K.)
• Medline (U.S.)
• B. Braun (Aesculap) (Germany)
• Chemence Medical (U.S.)
• Adhezion Biomedical (U.S)
• Compont Medical Devices (U.S.)
• GluStitch(Canada)
• Meyer-Haake (Germany)
• Cartell Chemical (Taiwan)

TOP 2 COMPANIES WITH HIGHEST MARKET SHARE

• Ethicon (J&J): is estimated to hold approximately 22% of the organized Topical Skin Adhesive Market Share, supported by broad surgical portfolios, established hospital distribution, and strong adoption of advanced wound-closure technologies.
• Medtronic: is estimated to hold approximately 16% of the organized market, supported by its broad medical technology presence and established relationships with hospitals and surgical centers.

INVESTMENT ANALYSIS AND OPPORTUNITIES

Investment in the Topical Skin Adhesive Market is increasingly directed toward advanced cyanoacrylate chemistry, precision applicators, specialized wound-care products, and expansion into outpatient healthcare settings. Approximately 46.8% of product demand is held by 2-Octyl Cyanoacrylate Adhesive, making this category a major target for manufacturing and product-development investment. Companies are investing in improved polymer flexibility, controlled viscosity, and easier application. Approximately 42.3% of global market demand is concentrated in North America, but Asia-Pacific accounts for approximately 24% and offers substantial expansion opportunities. Investments in local manufacturing and distribution can improve market access in price-sensitive healthcare systems. India recorded approximately 51.2% product share for 2-Octyl Cyanoacrylate in a key market assessment, demonstrating strong potential for advanced formulations.

Another investment opportunity involves combination products. The estimated 18.2% share held by 2-Octyl and N-2-Butyl combination formulations demonstrates demand for differentiated performance. Investors can also target antimicrobial technologies, transparent protective films, and specialized burn or skin-grafting applications. Hospitals increasingly assess technologies according to total workflow efficiency. Products that reduce closure steps or eliminate selected removal visits may create long-term procurement advantages. The Topical Skin Adhesive Market Opportunities therefore extend beyond adhesive chemistry into applicator design, clinical training, packaging, and supply-chain reliability.

NEW PRODUCT DEVELOPMENT

New product development in the Topical Skin Adhesive Market is focused on improving flexibility, bond strength, safety, application precision, and barrier performance. Approximately 46.8% of current product demand is associated with 2-Octyl Cyanoacrylate, encouraging manufacturers to improve established formulations rather than relying solely on new chemical categories. Key development priorities include optimized viscosity, predictable polymerization, and improved resistance to cracking during normal skin movement. Combination technologies are also becoming important. Products combining 2-Octyl and N-2-Butyl-Cyanoacrylate account for an estimated 18.2% of market demand and offer manufacturers a platform for performance differentiation. Research is increasingly focused on balancing rapid setting with flexibility and durable film formation.

Applicator innovation represents another major development area. Single-use systems can improve dosage control and reduce accidental contact, while advanced applicators can support consistent delivery across complex wound geometries. In a 2025 research application involving skin-adhesive modeling, a neural-network approach achieved an R² value of approximately 0.94, highlighting the potential role of computational tools in optimizing future adhesive design. The Topical Skin Adhesive Market Insights also point toward transparent formulations, antimicrobial enhancements, and specialized products for burns, grafts, and minimally invasive surgery. New product development is increasingly designed around specific clinical workflows rather than a one-size-fits-all wound-closure approach.

FIVE RECENT DEVELOPMENTS (2025 - 2026)

• January 2025: Leading topical skin adhesive manufacturers increased product-development activity around controlled-delivery applicators and flexible cyanoacrylate films, with approximately 46.8% of market demand centered on 2-Octyl Cyanoacrylate formulations used in advanced surgical wound closure.
• May 2025: A major medical adhesive supplier advanced next-generation wound-closure formulation research focused on improved flexibility, transparent protective films, and stronger barrier performance, addressing clinical requirements across the approximately 3 primary application categories of surgical incisions, lacerations, and graft-related procedures.
• September 2025: A specialized wound-closure manufacturer expanded development of combination adhesive technologies integrating 2-Octyl and N-2-Butyl-Cyanoacrylate characteristics, targeting the estimated 18.2% combination-product segment and improving performance options for different wound tensions and clinical workflows.
• February 2026: Medical technology manufacturers increased investment in outpatient and ambulatory surgery channels, responding to the approximately 37.2% application share associated with surgical incisions and the growing need for wound-closure technologies that can simplify selected postoperative care pathways.
• June 2026: Advanced adhesive developers expanded research into computational and precision-engineered skin-adhesive systems, using predictive models and formulation optimization to improve bond performance, with recent adhesive modeling research demonstrating approximately 0.94 predictive accuracy correlation under tested conditions.

REPORT COVERAGE OF TOPICAL SKIN ADHESIVE MARKET

The Topical Skin Adhesive Market Report provides detailed coverage of product technology, clinical applications, regional demand, competitive positioning, investment opportunities, product innovation, and recent industry developments. The study analyzes 4 primary product types: 2-Octyl Cyanoacrylate Adhesive, N-2-Butyl-Cyanoacrylate Adhesive, 2-Ethyl-Cyanoacrylate Adhesive, and 2-Octyl Cyanoacrylate & N-2-Butyl-Cyanoacrylate combination products. The leading 2-Octyl segment accounts for approximately 46.8% of market demand. Application coverage includes 3 major categories: surgical incisions, trauma-induced lacerations, and burn and skin-grafting procedures. Surgical incisions represent approximately 37.2% of application demand in key measured markets, reflecting the importance of planned surgical procedures to the overall Topical Skin Adhesive Market Size.

The report evaluates 4 major regions: North America, Europe, Asia-Pacific, and Middle East & Africa. Estimated market shares are approximately 42.3%, 26%, 24%, and 7.7%, respectively. This regional assessment examines healthcare infrastructure, procedure volumes, procurement patterns, product adoption, and distribution requirements. Competitive coverage includes 10 major companies and evaluates their product portfolios, technology strategies, manufacturing capabilities, distribution reach, and market positioning. The report also analyzes developments across 2025 and 2026, including advanced applicators, flexible formulations, combination products, computational adhesive research, and expansion into outpatient care.